Book chapter · 2020
5. From natural products to drugs
De Gruyter eBooks, 125–154 · Published 24 February 2020 · DOI 10.1515/9783110579352-006
In brief
“5. From natural products to drugs” is a 2020 book chapter by David J. Newman, published in De Gruyter eBooks. OpenAlex counts 3 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 3
- Most cited in
- 2025 (2)
- Field-weighted impact
- 0.28
- Authors
- 1
Abstract
It is frequently assumed, particularly in the last 15 plus years, that “Natural Product Structures” are no longer a source of drugs in the twenty-first century. In fact, this is not at all true. Even today, in the search for novel agents against manifold diseases, natural product structures, some quite old and some quite recent… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Newman, D. J. (2020). 5. From natural products to drugs. De Gruyter eBooks, 125–154. https://doi.org/10.1515/9783110579352-006
MLA 9
Newman, David J. “5. From natural products to drugs.” De Gruyter eBooks, 2020, pp. 125–154. https://doi.org/10.1515/9783110579352-006.
Chicago
Newman, David J. 2020. “5. From natural products to drugs.” De Gruyter eBooks: 125–154. https://doi.org/10.1515/9783110579352-006.
Harvard
Newman, D. J. (2020) ‘5. From natural products to drugs’, De Gruyter eBooks, pp. 125–154. doi:10.1515/9783110579352-006.
IEEE
D. J. Newman, “5. From natural products to drugs,” De Gruyter eBooks, pp. 125–154, 2020, doi: 10.1515/9783110579352-006.
BibTeX
@incollection{newman2020from,
title = {{5. From natural products to drugs}},
author = {Newman, David J.},
booktitle = {De Gruyter eBooks},
publisher = {De Gruyter},
year = {2020},
pages = {125--154},
doi = {10.1515/9783110579352-006},
url = {https://doi.org/10.1515/9783110579352-006}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- natural products
- drug discovery
- FDA-approved drugs
- clinical trials
- anticancer agents
- antiviral agents
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Newman, D. J. (2020). 5. From natural products to drugs. De Gruyter eBooks, 125–154. https://doi.org/10.1515/9783110579352-006
How many times has this paper been cited?
3 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
David J. Newman.
What is the DOI of this paper?
10.1515/9783110579352-006. The permanent link is https://doi.org/10.1515/9783110579352-006.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.